Outcomes of refractory or relapsed Hodgkin lymphoma patients with post autologous stem cell transplantation brentuximab vedotin maintenance : a French multicenter observational cohort study-Reference-Cited by-同舟云学术

Outcomes of refractory or relapsed Hodgkin lymphoma patients with post autologous stem cell transplantation brentuximab vedotin maintenance : a French multicenter observational cohort study

Published:2021-12-30 Issue: Volume: Page:
ISSN:1592-8721
Container-title:Haematologica
language:
Short-container-title:haematol

Author:

Marouf Amira,Cottereau Anne Segolene,Kanoun Salim,Deschamps Paul,Meignan Michel,Franchi Patricia,Sibon David,Antoine Clara,Gastinne Thomas,Borel Cecile,Hammoud Mohammad,Sicard Guillaume,Gille Romane,Cavalieri Doriane,Stamatoullas Aspasia,Filliatre-Clement Lauriane,Lazarovici Julien,Chauchet Adrien,Fornecker Luc-Matthieu,Amorin Sandy,Rocquet Mathieu,Raus Nicole,Burroni Barbara,Rubio Marie Therese,Bouscary Didier,Quittet Philippe,Casasnovas Rene Olivier,Brice Pauline,Ghesquieres Herve,Tamburini Jérôme,Deau Benedicte

Abstract

Not available.

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequencing novel agents in the treatment of classical Hodgkin lymphoma;Expert Review of Hematology;2023-11-16

2. Brentuximab vedotin consolidation therapy after autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma patients in the Czech Republic;Onkologie;2023-10-05

3. Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary;Annals of Hematology;2023-07-10

4. Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA;British Journal of Haematology;2023-05-16

5. Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes;Haematologica;2023-04-27